Multiple sclerosis (MS) is an inflammatory, immune-mediated disease that attacks nerves coated with myelin in the brain.
Myelin acts much like the rubber coating of electrical wires to keep the electrical signals from escaping and moving forward.
Destroying the myelin and the nerve producing varying degrees of physical disability and psychological problems within 20–25 years in more than 30% of patients.
MS can be asymptomatic for months interspersed with debilitating episodes that can last many weeks and affect different anatomic locations. Multiple sclerosis, or MS, is a long-lasting auto-immune disease that can affect your brain, spinal cord, and optic nerves in your eyes. It can cause problems with vision, balance, muscle control, and other basic body functions.
The effects are often different for everyone who has the disease. It is often called the ‘great imitator’ because it is often confused with other conditions before it gets diagnosed.
The cause of multiple sclerosis is unknown. It’s considered an autoimmune disease in which the body’s immune system attacks its own tissues. It has been hypothesized that MS results from an environmental agent, exposure, or event such as a viral or bacterial infection, exposure to chemicals, or lack of sun exposure, combined with a genetic predisposition to immune dysfunction. Risk factors for MS include higher altitudes and low sun exposure, thought to result from Vitamin D deficiency.
Treatment of multiple sclerosis (MS) is twofold: immunomodulatory therapy (IMT) for the immune disorder and those to relieve or modify symptoms. IMT is to reduce the frequency of relapses and slow the progression. For the long-term and progressive relapsing MS, Mitoxantrone is the approved treatment. A clinically isolated syndrome (CIS) (a single episode of neurologic symptoms) with immune modulators has not become standard practice but one studyshowed evidence that treating CIS with the drug teriflunomide delays the progression to MS.
Urinary symptoms are very common in MS. Bladder problems are a source of significant distress, affecting the person’s family, social, psychological, and work responsibilities. Urinary or bladder dysfunction can be a failure of urine storage, failure to empty, or both. Patients with impaired urinary storage have a small, spastic bladder with excess contractions of the bladder muscle. Symptoms may include urgency, frequency, incontinence, and excess nighttime urination. Urinary tract infections can result from MS-related bladder dysfunction.
Urinary catheters help by keeping the bladder empty so that it doesn’t spasm and cause leakage or because the bladder cannot empty on its own and overfills. Both spasms and overfilling can lead to urinary incontinence. It is important to fully empty the bladder in order to prevent infection, bladder stones, and kidney damage, among other things. Many people have found intermittent catheters to be the best way to do so.
While there are many different types of catheters, those who choose intermittent self-catheterization choose so for the freedom, independence, and convenience it grants them. Once people get the hang of it and establish an effective bladder program, users are able to self-cath in a variety of places, not just limited to a bathroom. This routine becomes the new norm!
For MS patients, CompactCath eliminates all possible worries when it comes to self-cathing with MS. Not only is CompactCath portable, but it’s easy to use.
It’s made out of state-of-the-art PVC plastic that does not kink when coiled. It also comes pre-lubricated, so the hassle and mess of lubrication is not even a concern. Finally, CompactCath comes with funnel-control, leading to minimal urine spill and mess, all while fitting in your pocket. Request your free samples of CompactCath below.